Skip to content
Home/Companies/HealthTech/Gnosco

Gnosco

HealthTech·Sweden·Exited 2025·Held 7yr
Entry
2018
Hold
7yr
Exit
2025

Who owns Gnosco?

Gnosco is a Swedish HealthTech company, now owned by Omda, which acquired it in 2025 from Almi Invest.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Almi Invest
Investor
Almi Invest
Almi Invest (Regional funds) · 2009 · VC

Key facts

HQSweden
SectorHealthTech
StatusAcquired
Exit Type
Trade Sale
Buyer
Omda
Exit Year
2025

More from Almi Invest (Regional funds)

Other portfolio companies in the same fund.

Cellevate
Active
BiotechSweden· 2026
CubaseBio
Active
BiotechSweden· 2026
DAJE Prevent
Active
MedTechSweden· 2026
Permitify
Active
SaaSSweden· 2026
Radar Reticence
Active
SoftwareSweden· 2026
Rivus
Active
SoftwareSweden· 2026

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Gnosco?

Gnosco is now owned by Omda, which acquired it in 2025 from Almi Invest.

When did Omda acquire Gnosco?

Omda acquired Gnosco in 2025, buying from Almi Invest.

Who did Gnosco sell to?

Almi Invest sold Gnosco to Omda in 2025 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue